Australia TGA ARTG recordSoft-tissue biopsy needle, single-use
Australia TGA ARTG Registered Device · Bard Australia Pty Ltd · Angiomed GmbH & Co Medizintechnik KG · Class IIa · Started May 23, 2011
Good Name: Bard Australia Pty Ltd - Soft-tissue biopsy needle, single-use
- Risk Class
- Class IIa
- Product Type
- Single Device Product
- ARTG Category
- General
- Start Date
- May 23, 2011
- Effective Date
- May 23, 2011
- Country
- Germany
- Address
- Wachhausstrasse 6, KARLSRUHE, 76227
Intended for percutaneous punctures into organs, tissues and vessels to obtain samples for cytology, also intended for percutaneous punctures for the introduction of guide wires.
Access comprehensive regulatory information for Soft-tissue biopsy needle, single-use in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIa is sponsored by Bard Australia Pty Ltd, manufactured by Angiomed GmbH & Co Medizintechnik KG in Germany. The device registration started on May 23, 2011.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.